Clinical pharmacists in promoting the rational use of angiotensin-converting enzyme inhibitors in the CCU

VernacularTitle:临床药师在冠心病监护病区促进血管紧张素转换酶抑制剂合理使用的成效
Author: Xiaobo ZHAI ¹ ; Yamin WANG ; Rong BAI ; Zhigao HE
Author Information

1. 同济大学附属东方医院药学部
Keywords: angiotensin-converting enzyme inhibitors (ACEI); rationality; clinical pharmacist
From: Journal of Pharmaceutical Practice 2017;35(5):472-474,478
CountryChina
Language:Chinese
Abstract: Objective To improve the rational use of angiotensin-converting enzyme inhibitors (ACEI).Methods Clinical pharmacists reviewed ACEI use for the patients admitted into coronary heart disease care unit (CCU) during May 2012 to May 2013 to analyze the rational use of ACEI according to the expert consensus standards, guidelines and drug instructions of ACEI without any interventions.Clinical pharmacists intervened the irrational use of ACEI based on the same standard from June 2013 to May 2015.Results By comparing the data before and after intervention, it was found that the percentage of ACEI use increased from 80.1％ to 98.9％.The percentage of initial ACEI overdose was dropped from 21.4％ to 0.9％, and the percentage of under dose was decreased from 4.7％ to 0.5％, which was statistically significant.Conclusion Clinical pharmacists can play a leading role in promoting the rational use of ACEI.